Entry |
|
Name |
Ulinastatin (JP18); Miraclid (TN) |
Remark |
Therapeutic category: | 3999 |
|
Efficacy |
Trypsin inhibitor |
Target |
|
Pathway |
hsa04974 | Protein digestion and absorption |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
B02AB Proteinase inhibitors
B02AB05 Ulinastatin
D05183 Ulinastatin (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D05183 Ulinastatin (JP18)
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Chymotrypsin family
CTRB
D05183 Ulinastatin (JP18) <JP>
PRSS
D05183 Ulinastatin (JP18) <JP>
ELANE
D05183 Ulinastatin (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D05183 Ulinastatin
|
Other DBs |
|
LinkDB |
|